Product Details for NDA 010348
SPARINE (PROMAZINE HYDROCHLORIDE)
10MG
Marketing Status: Discontinued
25MG
Marketing Status: Discontinued
50MG
Marketing Status: Discontinued
100MG
Marketing Status: Discontinued
200MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
SPARINE (PROMAZINE HYDROCHLORIDE)
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
25MG
Marketing Status: Discontinued
Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
SPARINE (PROMAZINE HYDROCHLORIDE)
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
50MG
Marketing Status: Discontinued
Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
SPARINE (PROMAZINE HYDROCHLORIDE)
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
100MG
Marketing Status: Discontinued
Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
SPARINE (PROMAZINE HYDROCHLORIDE)
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
200MG
Marketing Status: Discontinued
Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: SPARINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010348
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information